Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Cash Flows from Operating Activities    
Net loss $ (3,391) $ (13,069)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on lease modification (3,139) 0
Stock-based compensation expense 3,113 4,893
Depreciation and amortization 2,201 1,448
Changes in fair value of derivative liabilities (198) 292
Reduction in transaction costs allocated to derivative liabilities upon Business Combination 0 (3,745)
Non-cash interest expense 961 948
Inventory reserve (505) 124
Other non-cash expenses 0 77
Changes in operating assets and liabilities:    
Inventory (2,170) 3,078
Prepaids and other assets (14) (828)
Accounts payable 125 1,554
Accrued expenses (4,082) 162
Deferred revenue (585) (1,726)
Operating lease right-of-use assets and liabilities (4,872) (261)
Other liabilities 176 316
Net cash used in operating activities (12,380) (6,737)
Cash Flows from Investing Activities    
Purchase of property and equipment (518) (784)
Net cash used in investing activities (518) (784)
Cash Flows from Financing Activities    
Payment of transaction costs related to the Business Combination 0 (4,150)
Proceeds from issuance of debt 0 7,500
Payment of debt issuance costs 0 (837)
Repayment of debt 0 (235)
Payments related to stock-based award activities (381) (288)
Net cash (used in) provided by financing activities (381) 1,990
Net decrease in cash, cash equivalents and restricted cash (13,279) (5,531)
Cash, cash equivalents and restricted cash at beginning of period 94,863 95,985
Cash, cash equivalents and restricted cash at end of period 81,584 90,454
Supplemental Disclosure    
Cash paid for taxes 10 9
Cash paid for interest 3,192 2,734
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Purchase of property and equipment in accounts payable and accrued liabilities 24 113
Reduction in transaction costs allocated to equity instruments 0 9,609
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 77,757 81,653
Restricted cash 3,827 8,801
Total cash, cash equivalents and restricted cash $ 81,584 $ 90,454